Morgan Stanley’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-657,354
Closed -$24.8M 7987
2021
Q1
$24.8M Buy
657,354
+615,789
+1,482% +$23.2M ﹤0.01% 1720
2020
Q4
$707K Buy
41,565
+26,876
+183% +$457K ﹤0.01% 4862
2020
Q3
$69K Sell
14,689
-8,048
-35% -$37.8K ﹤0.01% 5592
2020
Q2
$139K Sell
22,737
-37,437
-62% -$229K ﹤0.01% 5243
2020
Q1
$136K Buy
60,174
+8,387
+16% +$19K ﹤0.01% 5054
2019
Q4
$237K Sell
51,787
-109,393
-68% -$501K ﹤0.01% 5346
2019
Q3
$624K Sell
161,180
-97,137
-38% -$376K ﹤0.01% 4582
2019
Q2
$1.56M Buy
258,317
+237,933
+1,167% +$1.44M ﹤0.01% 3967
2019
Q1
$273K Sell
20,384
-56,723
-74% -$760K ﹤0.01% 4897
2018
Q4
$718K Buy
77,107
+10,838
+16% +$101K ﹤0.01% 4538
2018
Q3
$923K Sell
66,269
-33,681
-34% -$469K ﹤0.01% 4598
2018
Q2
$1.58M Buy
99,950
+5,245
+6% +$83K ﹤0.01% 4285
2018
Q1
$1.63M Sell
94,705
-256,961
-73% -$4.41M ﹤0.01% 4182
2017
Q4
$7.71M Buy
351,666
+298,399
+560% +$6.54M ﹤0.01% 2655
2017
Q3
$2.18M Sell
53,267
-83,509
-61% -$3.42M ﹤0.01% 3801
2017
Q2
$4.12M Buy
136,776
+15,092
+12% +$454K ﹤0.01% 3055
2017
Q1
$4.4M Buy
121,684
+13,750
+13% +$497K ﹤0.01% 2981
2016
Q4
$5.41M Buy
107,934
+75,424
+232% +$3.78M ﹤0.01% 2906
2016
Q3
$1.71M Buy
32,510
+22,568
+227% +$1.19M ﹤0.01% 3624
2016
Q2
$411K Sell
9,942
-43,024
-81% -$1.78M ﹤0.01% 4544
2016
Q1
$2.15M Buy
52,966
+42,363
+400% +$1.72M ﹤0.01% 3292
2015
Q4
$440K Sell
10,603
-745
-7% -$30.9K ﹤0.01% 4630
2015
Q3
$175K Sell
11,348
-8,199
-42% -$126K ﹤0.01% 5149
2015
Q2
$485K Sell
19,547
-57,318
-75% -$1.42M ﹤0.01% 4735
2015
Q1
$1.76M Buy
76,865
+70,051
+1,028% +$1.6M ﹤0.01% 3695
2014
Q4
$184K Sell
6,814
-16,107
-70% -$435K ﹤0.01% 5287
2014
Q3
$269K Buy
22,921
+4,934
+27% +$57.9K ﹤0.01% 4976
2014
Q2
$280K Buy
17,987
+12,625
+235% +$197K ﹤0.01% 4975
2014
Q1
$106K Buy
5,362
+4,901
+1,063% +$96.9K ﹤0.01% 5428
2013
Q4
$8K Buy
+461
New +$8K ﹤0.01% 6086